Trials / Completed
CompletedNCT03915860
Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris
A Multi-Center Study to Evaluate Subject Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 9 Years
- Healthy volunteers
- Not accepted
Summary
Participant Reported Outcomes with use of Trifarotene 50 μg/g Cream in participants with Moderate Facial and Truncal Acne Vulgaris
Detailed description
There was no formal hypothesis to be tested. Approximately 50 subjects would be enrolled to evaluate the subject reported outcomes (quality of life and satisfaction survey). The sample size was not based on any formal hypothesis testing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Trifarotene | Topical Cream |
Timeline
- Start date
- 2019-03-27
- Primary completion
- 2019-12-23
- Completion
- 2019-12-23
- First posted
- 2019-04-16
- Last updated
- 2021-12-15
- Results posted
- 2021-12-15
Locations
9 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03915860. Inclusion in this directory is not an endorsement.